Both in Biotechnology
BioCryst Pharmaceuticals vs Vir Biotechnology
Over the past year BCRX returned +24.9% and VIR returned +100.4%; their daily moves had a correlation of 0.24.
BCRX +24.9% VIR +100.4%Growth of $1, one year, split-adjusted
| Metric | BCRX | VIR |
|---|---|---|
| Price | $8.57 | $11.22 |
| Market cap | $2.19B | $1.90B |
| Today | +3.94% | +2.00% |
| 1 month | +5.8% | −4.8% |
| 6 months | −5.1% | +12.1% |
| Year to date | +9.9% | +86.1% |
| 1 year | +17.1% | +88.3% |
| Revenue growth (YoY) | +33.6% | +19582.5% |
| Gross margin | 98.2% | 100.0% |
| Net margin | 35.9% | 33.5% |
| P/E (TTM) | — | — |
| Price / sales | 2.3× | 6.3× |
| Net cash | -$471.6M | $532.7M |
| Dividend yield | — | — |
| Volatility (60d) | 44.9% | 51.5% |
| Short % of float | 10.9% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).